Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy

NCT05141383 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT05141383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05141383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Completed
Start date
May 4, 2022
Completion date
September 3, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy donors, prostate cancer